Articles published by GlobeNewswire

...

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

Today 7:45 EST

From Helus Pharma

Via GlobeNewswire

FuelCell Energy Announces First Quarter 2026 Results Conference Call on March 9, 2026 at 10:00 A.M. Eastern Time

Today 7:30 EST

From FuelCell Energy, Inc.

Via GlobeNewswire

Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity

Today 7:30 EST

From Promatix Biosciences, Ltd.

Via GlobeNewswire

Apogee Therapeutics to Participate in Upcoming March Conferences

Today 7:30 EST

From Apogee Therapeutics

Via GlobeNewswire

Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract

Today 7:30 EST

From Paratek Pharmaceuticals, Inc.

Via GlobeNewswire

Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience

Today 7:30 EST

From Stardust Power Inc.

Via GlobeNewswire

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Today 7:30 EST

From Mainz BioMed NV

Via GlobeNewswire

Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency

Today 7:30 EST

From Rekor Systems

Via GlobeNewswire

Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company

Today 7:30 EST

From Olenox Industries Inc.

Via GlobeNewswire

Applied Materials Awards Suppliers for Outstanding Performance

Today 7:30 EST

From Applied Materials, Inc.

Via GlobeNewswire

Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases

Today 7:30 EST

From Alveus Therapeutics Inc

Via GlobeNewswire

ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company

Today 7:29 EST

From ADW Capital Management, LLC

Via GlobeNewswire

PTLE Announces 1-for-80 Share Consolidation

Today 7:25 EST

From PTL Limited

Via GlobeNewswire

GDS Announces Adjournments of Extraordinary General Meeting and Additional Shareholders Meetings to be Reconvened on March 10, 2026

Today 7:15 EST

From GDS Holdings Limited

Via GlobeNewswire

Learning Tree International Awarded Multi-Year Sole-Award NATO NCIA Commercial Training Services Contract – IFB-CO-423236

Today 7:11 EST

From Learning Tree International USA, Inc

Via GlobeNewswire

Xometry Reports Record Fourth Quarter and Strong Full Year 2025 Results

Today 7:05 EST

From Xometry, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Today 7:05 EST

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

Today 7:05 EST

From Treace Medical Concepts, Inc.

Via GlobeNewswire

Xometry Announces CEO Succession Plan

Today 7:05 EST

From Xometry, Inc.

Via GlobeNewswire

New WJ V Nonverbal Cognitive Assessment from Riverside Insights Closes Critical Gap in Student Evaluation

Today 7:02 EST

From Riverside Insights

Via GlobeNewswire

New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies

Today 7:01 EST

From Invivyd

Via GlobeNewswire

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

Today 7:01 EST

From Beam Therapeutics

Via GlobeNewswire

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

Today 7:01 EST

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025

Today 7:00 EST

From Shoals Technologies Group

Via GlobeNewswire

Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Today 7:00 EST

From Arvinas Inc.

Via GlobeNewswire

Garrett Motion Announces Participation at the Bank of America Global Automotive Summit

Today 7:00 EST

From Garrett Motion Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)

Today 7:00 EST

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX

Today 7:00 EST

From OTC Markets

Via GlobeNewswire

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences

Today 7:00 EST

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026

Today 7:00 EST

From Atea Pharmaceuticals, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.